Hemosiderosis other diagnostic studies: Difference between revisions
| Line 7: | Line 7: | ||
==Other diagnostic studies== | ==Other diagnostic studies== | ||
Other diagnostic studies for [[IPH]] include [[ | Other diagnostic studies for [[IPH]] include: | ||
[[Sputum]] testing and [[bronchoalveolar lavage]], which demonstrates: | |||
*intact [[erythrocytes]] and hemosiderin-laden [[Macrophage|macrophages]] | |||
[[pulmonary function tests]], which demonstrates: | |||
*[[Restrictive Lung Disease|restrictive pattern]] of varying severity | |||
*Decreased [[DLCO]] | |||
==References== | ==References== | ||
Latest revision as of 04:41, 28 September 2020
|
Hemosiderosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemosiderosis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Hemosiderosis other diagnostic studies |
|
Risk calculators and risk factors for Hemosiderosis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other diagnostic studies for IPH include sputum testing and bronchoalveolar lavage (BAL) for intact erythrocytes and hemosiderin-laden macrophages, which demonstrate pulmonary hemorrhage, and pulmonary function tests, which generally shows a restrictive pattern of varying severity and decreased DLCO.
Other diagnostic studies
Other diagnostic studies for IPH include: Sputum testing and bronchoalveolar lavage, which demonstrates:
- intact erythrocytes and hemosiderin-laden macrophages
pulmonary function tests, which demonstrates:
- restrictive pattern of varying severity
- Decreased DLCO